New pan-genotype NS5A inhibitor works well on G4 in trials Nov 16, 2015 14:53:12 GMT Quote Select PostDeselect PostLink to PostMemberGive GiftBack to Top Post by Alsdad on Nov 16, 2015 14:53:12 GMT Promising:seekingalpha.com/news/2930966-pharco-pharma-reports-100-percent-hcvminus-4-cure-rate-with-sovaldi-ravidasvir-combo-in-late-stage-study